Photocure ASA (OSE: PHO) today reported Hexvix®/Cysview® revenues of NOK 134.1 million in the third quarter of 2025 (Q3 2024: NOK ...
Avvio Medical, Inc., a clinical-stage medical device company developing next-generation kidney stone treatment technologies, ...
4d
Photocure (OB:PHO): Revenue Forecasts Signal 14.5% Growth, Valuation Below Sector Ahead of Earnings
Photocure (OB:PHO) continues to operate at a loss but has successfully reduced its losses by 12.8% per year over the last five years. Revenue is expected to grow at a robust 14.5% per year and ...
Photocure ASA (($NO:PHO)) has held its Q3 earnings call. Read on for the main highlights of the call. Photocure ASA’s recent earnings call ...
The global Disposable Endoscopes Market , valued at US$0.84 billion in 2024, stood at US$0.95 billion in 2025 and is ...
Flexible cystoscopy is the most common office-based procedure performed by urologists to diagnose and treat lower urinary tract conditions. The phase 3 NRG Oncology GU005 trial of SBRT vs MH-IMRT for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback